
5-AMINO-1MQ
Nicotinamide Phosphoribosyltransferase Inhibitor
Size
50mg vial
Price
$50.00
In stock
Synthetic compound studied for its role in metabolic enzyme inhibition and cellular energy regulation in laboratory research.
- Clearly labeled 50mg vial vial
- Synthetic research compound
- Guest checkout — order in minutes
For laboratory research use only. Not for human or veterinary use.
5-AMINO-1MQ is a synthetic small molecule designed to inhibit nicotinamide phosphoribosyltransferase (NAMPT), an enzyme involved in cellular metabolism. It is structurally related to quinoline derivatives and is used in research to explore metabolic pathways.
This compound is typically supplied as a lyophilized powder for laboratory use. Its chemical structure allows it to interact with specific enzymatic targets, making it a valuable tool for studying metabolic regulation in vitro.
- Compound
- 5-AMINO-1MQ
- Also known as
- 5-Amino-1-methylquinolinium, 5-AMINO-1-MQ
- Quantity
- 50mg vial
- Compound type
- Synthetic research compound
- Form
- Lyophilized research material
- Research category
- NNMT Research Compound
- Intended use
- Laboratory research only
In laboratory research, 5-AMINO-1MQ is utilized to investigate the modulation of NAD+ biosynthesis pathways and their impact on cellular metabolism. It serves as a tool to study metabolic signaling and energy homeostasis in various cell models.
Research involving this compound often focuses on understanding the biochemical mechanisms of enzyme inhibition and its effects on metabolic processes. It is used to elucidate pathways relevant to metabolic regulation and cellular energy dynamics.
This information is provided for compound identification and research context only. It is not medical advice and is not a representation that this material is safe or effective for any use in humans or animals.
Orders are processed after payment confirmation and order review.
Shipping methods, carriers and timelines are described in the Shipping Policy. Orders may be reviewed and may be declined at our discretion.



